I agree that this site is using cookies. You can find further informations here.
X
Dreyling, Anna Dominika
25  results:
Search for persons X
?
1

Elucidating the role of BEACH domain-containing proteins, w..:

Dreyling, Anna Dominika
http://resolver.sub.uni-goettingen.de/purl?ediss-11858/14033.  , 2022
Link: http://resolver.sub.uni-..
 
?
2

Elucidating the role of BEACH domain-containing proteins, w..:

Dreyling, Anna Dominika , 2022
Link: https://nbn-resolving.de..
 
?
3

Lisocabtagene maraleucel in follicular lymphoma: the phase ..:

Morschhauser, Franck ; Dahiya, Saurabh ; Palomba, M. Lia...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
4

Author Correction: Lisocabtagene maraleucel in follicular l..:

Morschhauser, Franck ; Dahiya, Saurabh ; Palomba, M. Lia...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
5

Clinical Practice Recommendations for Hematopoietic Cell Tr..:

Iqbal, Madiha ; Kumar, Ambuj ; Dreger, Peter...
Transplantation and Cellular Therapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
6

PB2304: FIVE-YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALI..:

Duell, Johannes ; Abrisqueta, Pau ; Dreyling, Martin...
HemaSphere.  7 (2023)  S3 - p. e7389505 , 2023
Link: https://doi.org/10.1097/..
 
?
7

Oral Abstract: IBCL-098 TRANSCEND FL: Phase II Study Result..:

Nastoupil, Loretta J. ; Dahiya, Saurabh ; Palomba, M. Lia...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S147 , 2023
Link: https://doi.org/10.1016/..
 
?
8

POSTER: IBCL-098 TRANSCEND FL: Phase II Study Results of Li..:

Nastoupil, Loretta J. ; Dahiya, Saurabh ; Palomba, M. Lia...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S209 , 2023
Link: https://doi.org/10.1016/..
 
?
9

PTCY-Based Haploidentical Donor Transplantation versus HLA-..:

Haebe, Sarah ; Fraccaroli, Alessia ; Stauffer, Elena...
Cancers.  15 (2023)  21 - p. 5246 , 2023
Link: https://doi.org/10.3390/..
 
?
10

IBCL-098 TRANSCEND FL: Phase II Study Results of Lisocabtag..:

Nastoupil, Loretta J. ; Dahiya, Saurabh ; Palomba, M. Lia...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S447-S448 , 2023
Link: https://doi.org/10.1016/..
 
?
11

ABCL-388 L-MIND: Safety and Efficacy of Tafasitamab in Pati..:

Duell, Johannes ; Jurczak, Wojciech ; Liberati, Anna Marina...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S375 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Poster: ABCL-388 L-MIND: Safety and Efficacy of Tafasitamab..:

Duell, Johannes ; Jurczak, Wojciech ; Liberati, Anna Marina...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S164 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Long-term outcomes from the Phase II L-MIND study of tafasi..:

Duell, Johannes ; Maddocks, Kami J. ; González-Barca, Eva...
Haematologica.  106 (2021)  9 - p. 2417-2426 , 2021
Link: https://doi.org/10.3324/..
 
?
14

Long-term outcomes from the phase II L-MIND study of tafasi..:

Duell, Johannes ; Maddocks, Kami J. ; González-Barca, Eva...
Haematologica.  , 2021
Link: https://doi.org/10.3324/..
 
?
15

COVID-19 in Patients Receiving CD20-depleting Immunochemoth..:

Gaitzsch, Erik ; Passerini, Verena ; Khatamzas, Elham...
HemaSphere.  5 (2021)  7 - p. e603 , 2021
Link: https://doi.org/10.1097/..
 
1-15